World's Best Scientists 2026 revealed!
Cancer Research
H-index 86

Cancer Research

0008-5472

Published by: AACR

https://cancerres.aacrjournals.org/

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 109 2293 4885 68

Additional Metrics

Number of Best Scientists*: 6045
Documents by Best Scientists*: 10081
Top 100 Ranked Scientists*: 214
SCIMAGO H-index: 510
SCIMAGO SJR: 3.879
Impact Factor: 16.6

Overview

Top Research Topics at Cancer Research?

Cancer Research mainly tackles studies in Cancer research, Cancer, Internal medicine, Pathology and Breast cancer. In the journal, Cell culture, Cancer cell, Carcinogenesis, Immunology and Metastasis are investigated in conjunction with one another to address concerns in Cancer research research. The work on Cell culture tackled in the journal brings together disciplines like Molecular biology and Cell.

It holds forums on Molecular biology that merges themes from other disciplines such as DNA, Biochemistry, Gene expression and Gene. Cancer research presented in Cancer Research encompasses a variety of subjects, including Apoptosis, Cell growth and In vivo. The studies in In vivo featured incorporate elements of In vitro and Pharmacology.

It explores issues in Internal medicine which can be linked to other research areas like Gastroenterology, Endocrinology, Surgery and Oncology. The journal concentrates on Pathology topics that focus on Immunohistochemistry and Carcinoma. Most of the Breast cancer studies addressed also intersect with Gynecology.

  • Cancer research (38.50%)
  • Cancer (35.28%)
  • Internal medicine (24.20%)

What are the most cited papers published in the journal?

  • The Detection of Disease Clustering and a Generalized Regression Approach (9972 citations)
  • A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy: Mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent Smancs (5598 citations)
  • Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets (4909 citations)

Research areas of the most cited articles at Cancer Research:

The published articles are organized to reinforce research efforts on Cancer research, Pathology, Internal medicine, Molecular biology and Cancer. While Cancer research is the focus of the journal publications, it also provides insights into the studies of Cell culture, Carcinogenesis, Tumor suppressor gene, Cancer cell and Immunology. The journal articles deal with Molecular biology in conjunction with Biochemistry and similar fields in Cell biology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Cancer
  • Gene

The previous edition focused in particular on these issues:

Cancer Research investigates studies in Cancer, Cancer research, Breast cancer, Internal medicine and Oncology. Research on Cancer addressed in it frequently intersections with the field of Lung cancer. The journal facilitates discussions on Cancer research that incorporate concepts from other fields like Cancer cell, Metastasis, Immune system and Carcinogenesis.

While work presented in the journal provided substantial information on Breast cancer, it also covered topics in Radiation therapy and Disease. Studies on Internal medicine discussed in it link to the field of Gastroenterology. The Oncology works featured in Cancer Research incorporate elements from Biomarker (medicine) and Clinical trial.

The most cited articles from the last journal are:

  • Abstract GS3-00: First results from a phase III randomized clinical trial of standard adjuvant endocrine therapy (ET) +/- chemotherapy (CT) in patients (pts) with 1-3 positive nodes, hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) < 25: SWOG S1007 (RxPonder) (29 citations)
  • Replication Gaps Underlie BRCA-deficiency and Therapy Response (27 citations)
  • YTHDF1 Promotes Gastric Carcinogenesis by Controlling Translation of FZD7. (26 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Cancer Research (based on the number of publications) are:

  • John D. Minna (273 papers) published 6 papers at the last edition, 3 more than at the previous edition,
  • Robert M. Hoffman (256 papers) absent at the last edition,
  • Gordon B. Mills (251 papers) published 4 papers at the last edition, 6 less than at the previous edition,
  • Yusuke Nakamura (218 papers) absent at the last edition,
  • Wafik S. El-Deiry (213 papers) published 6 papers at the last edition, 4 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Cancer Research (based on the number of publications) are:

  • University of Texas MD Anderson Cancer Center (5277 papers) published 130 papers at the last edition, 181 less than at the previous edition,
  • Harvard University (4172 papers) published 170 papers at the last edition, 149 less than at the previous edition,
  • National Institutes of Health (3425 papers) published 49 papers at the last edition, 43 less than at the previous edition,
  • Johns Hopkins University (2038 papers) published 40 papers at the last edition, 47 less than at the previous edition,
  • Memorial Sloan Kettering Cancer Center (1833 papers) published 77 papers at the last edition, 87 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 30.32% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 26.66% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.95% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.87% of all publications and 50.52% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Related Fields

While information on research topics, contributing authors and institutions provide a rich understand of the content, Cancer Research Journal readers may also be interested in possible career applications or pathways related to the discussed topics. For instance, the field of cancer research and pathology presents numerous exciting job opportunities in nursing, clinical research, laboratory medicine, and other healthcare specialties.

A career as a nurse in the field of cancer research can be gratifying. However, the process of becoming a nurse requires meeting some licensing requirements. For instance, in North Carolina, those interested in becoming nurses need to understand the specific requirements to obtain a license. You can learn more about North Carolina nursing license requirements and the cost of obtaining a nursing license to facilitate planning and anticipating potential hurdles.

Opportunities are equally available for various roles in clinical research and laboratory medicine positions. Such roles often deal directly with developing new diagnostic techniques and testing potential treatments, specifically in the field of cancer research. Embarking on any of these career paths not only contributes to the global fight against cancer but could also lead to a rewarding professional journey.

Top Publications

  • Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion.

    Florida Voli;Emanuele Valli;Luigi Lerra;Kathleen Kimpton

    (2020)
    396 Citations
  • Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal

    (2023)
    324 Citations
  • Cancer-Associated Neurogenesis and Nerve-Cancer Cross-talk.

    Deborah A. Silverman;Vena K. Martinez;Patrick M. Dougherty;Jeffrey N. Myers

    (2021)
    239 Citations
  • Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer.

    Ali Ghoochani;En-Chi Hsu;Merve Aslan;Meghan A. Rice

    (2021)
    209 Citations
  • Retraction: A Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate Cancer

    Jianhua Wang;Jincheng Wang;Jinlu Dai;Younghun Jung

    (2021)
    194 Citations
  • Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance

    Abir Mukherjee;Chun Yi Chiang;Helen A. Daifotis;Kristin M. Nieman

    (2020)
    183 Citations
  • Towards Multidrug Adaptive Therapy.

    Jeffrey West;Li You;Jingsong Zhang;Robert A. Gatenby

    (2020)
    175 Citations
  • M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma.

    Xinyao Qiu;Shuai Yang;Shan Wang;Jianmin Wu

    (2021)
    155 Citations
  • Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small Cell Lung Carcinoma.

    Xiang Zheng;Andreas Weigert;Simone Reu;Stefan Guenther

    (2020)
    150 Citations
  • Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors.

    Hiroshi Sootome;Hidenori Fujita;Kenjiro Ito;Hiroaki Ochiiwa

    (2020)
    146 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare but not necessarily pursuing a traditional medical degree, there are several valuable online options. Careers like medical billing and coding are increasingly in demand, offering stability and flexibility in the healthcare industry. You can learn more about the field by exploring is medical billing and coding in demand.

If you're drawn to healthcare administration, an online HIM degree (Health Information Management) could be a smart choice. This path combines healthcare knowledge with management skills, preparing graduates for roles that support the medical infrastructure behind patient care.

Nutrition is another promising area with growing opportunities. Earning one of the most affordable online degrees in nutrition can open doors in dietetics, wellness coaching, or public health, blending science with practical impact on individual and community health.

For those interested in diagnostic technologies, attending an online ultrasound tech school offers a hands-on career pathway. This field focuses on imaging techniques critical to medical diagnosis and treatment, making it a rewarding choice for students passionate about both technology and patient care.

Best Scientists Contributing to This Journal

Recently Published Articles